Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Kara N Maxwell, MD, PhD

Assistant Professor of Medicine
Department: Medicine

Contact information
BRB Room 810
421 Curie Blvd
Philadelphia, PA 19104
BS (Genetics, Biochemistry)
University of Wisconsin-Madison, 1998.
PhD (Molecular and Cellular Biology)
Rockefeller University, 2006.
MD (Medicine)
Weill Cornell Medical College, 2007.
Post-Graduate Training
Internship in Internal Medicine, New York Presbyterian Hospital – Columbia Campus, 2007-2008.
Residency in Internal Medicine, New York Presbyterian Hospital – Columbia Campus, 2008-2010.
Fellowship in Hematology/Oncology, University of Pennsylvania, 2011-2014.
Postdoctoral Fellowship in Cancer Genetics, University of Pennsylvania, 2014-2015.
American Board of Internal Medicine, Internal Medicine, 2010.
American Board of Internal Medicine, Medical Oncology, 2014.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

cancer risk evaluation, breast cancer, hereditary breast ovarian cancer, Li Fraumeni Syndrome, Fanconi Anemia

Description of Research Expertise

I am a Medical Oncologist and PhD trained molecular and cellular biologist. My research interests are in the genetics of human disease, particularly familial cancers, and in the translation of genetic data for managing individuals at risk for cancer and for directing novel therapies for oncology patients.

Selected Publications

MacFarland SP, Maxwell KN: The differential diagnosis of a TP53 genetic testing result. Genetics in Medicine epub ahead of print, Jan 2018.

Breitenstein MK, Liu H, Maxwell KN, Pathak J, Zhang R: Electronic health record phenotypes for precision medicine: perspectives and caveats from treatment of breast cancer at a single institution. Clinical and Translational Science 11(1): 85-92, Jan 2018.

Maxwell KN, Wubbenhorst B, Wenz BM, De Sloover D, Pluta J, Emery L, Barrett A, Kraya AA, Anastopoulos IN, Yu S, Jiang Y, Chen H, Zhang NR, Hackman N, D'Andrea K, Daber R, Morrissette JJD, Mitra N, Feldman M, Domchek SM, Nathanson KL.: BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers. Nature Communications 8(1): 319, Aug 2017.

Nian X, Nagai Y, Jeffers C, Maxwell KN, Zhang H: Dietary influence on estrogens and cytokines in breast cancer. AIMS Molecular Science 4(3): 252-270, Jul 2017.

Slavin TP*, Maxwell KN*, Lilyquist J*, Vijai J*, Neuhausen SL, Hart SN, Ravichandran V, Thomas T, Maria A, Villano D, Schrader KA, Moore R, Hu C, Wubbenhorst B, Wenz BM, D'Andrea K, Robson ME, Peterlongo P, Bonanni B, Ford JM, Garber JE, Domchek SM, Szabo C, Offit K, Nathanson KL, Weitzel JN, Couch FJ (*shared first authorship): The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer 3: 22, June 2017.

Chen H, Jiang Y, Maxwell KN, Nathanson KL, Zhang N.: Allele-specific copy number estimation by whole exome sequencing. Ann Appl Stat 11(2): 1169-1192, June 2017.

Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, Carpenter E, Chodosh LA, DeMichele A: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer. Breast Cancer Research and Treatment 164(3): 627-638, May 2017.

Maxwell KN, Domchek SM, Nathanson KL, Robson ME: Population Frequency of Germline BRCA1/2 Mutations. Journal of Clinical Oncology 34(34): 4183-4185, Dec 2016.

Vijai J, Topka S, Villano D, Ravichandran V, Maxwell KN, Maria A, Thomas T, Gaddam P, Lincoln A, Kazzaz S, Wenz B, Carmi S, Schrader KA, Hart SN, Lipkin SM, Neuhausen SL, Walsh MF, Zhang L, Lejbkowicz F, Rennert H, Stadler ZK, Robson M, Weitzel JN, Domchek S, Daly MJ, Couch FJ, Nathanson KL, Norton L, Rennert G, Offit K: A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer. Cancer Discovery 6(11): 1267-1275, Nov 2016.

Jean S, Li J, Katsaros D, Wubbenhorst B, Maxwell KN, Fishbein L, McLane MW, Benedetto C, Canuto EM, Mitra N, Zhang L, Nathanson KL, Tanyi JL: Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations. Oncotarget 7(30): 48577-48585, Jul 2016.

back to top
Last updated: 09/05/2018
The Trustees of the University of Pennsylvania
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration